National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 5,295 cases where Vaccine is COVID19 and Manufacturer is MODERNA and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis



Case Details

This is page 11 out of 530

Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next


VAERS ID: 988325 (history)  
Form: Version 2.0  
Age: 60.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-01-06
Onset:2021-01-26
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025L20A / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Biopsy skin, Petechiae, Purpura, Rash, Type III immune complex mediated reaction, Vasculitis
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Vasculitis (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Hydrochlorothiazide last taken 2 weeks prior to vaccine administration Levothyroxine Albuterol as needed Daily multivitamin
Current Illness: None.
Preexisting Conditions: Anxiety, HLD, HTN, hypothyroidism, rosacea, liver steatosis secondary to obesity Migraine, impaired fasting glucose without diagnosis of T2DM, obesity with BMI 40.5
Allergies: Codeine and morphine intolerance Sulfa antibiotics-prior hives seen on administration in her 20s
Diagnostic Lab Data: Punch biopsy of rash with result pending at time of report.
CDC Split Type:

Write-up: Onset of Petechial/purpural rash along BLE starting in thighs B/L with spread to abdomen and BUE. Probable Type III Hypersensitivity vs vasculitis. Came to hospital 01/28/2021. Treated with PO steroids 60 mg PO prednisone with rapid improvement. Testing still pending.


VAERS ID: 988912 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Male  
Location: Nevada  
Vaccinated:2020-12-29
Onset:2021-01-21
   Days after vaccination:23
Submitted: 0000-00-00
Entered: 2021-01-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 LA / IM
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Petechiae, Rash maculo-papular
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: rosuvastatin, multivitamin
Current Illness:
Preexisting Conditions: hyperlipidemia
Allergies: latex
Diagnostic Lab Data:
CDC Split Type:

Write-up: petechial rash, maculopapular rash spreading from legs, abdomen, chest, back, and arms


VAERS ID: 989737 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Female  
Location: Connecticut  
Vaccinated:2021-01-04
Onset:2021-01-16
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-01-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 011L20A / 1 LA / IM

Administered by: Work       Purchased by: ?
Symptoms: Heavy menstrual bleeding, Menstrual disorder, Thrombosis
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: multivitamin
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data:
CDC Split Type:

Write-up: Received vaccine on 1/4. Started menstrual cycle on 1/16 which was 1 week early. 3 days into the cycle, heavy vaginal bleeding with large blot clots (golf ball size) starting on 1/20/201 and continuing until now 1/31, bleeding still going on.


VAERS ID: 990355 (history)  
Form: Version 2.0  
Age: 60.0  
Sex: Male  
Location: New York  
Vaccinated:2021-01-07
Onset:2021-01-11
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 011J20A / 1 RA / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Deep vein thrombosis, Ultrasound Doppler
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: VALSARTAN; ALFUZOSIN; BABY ASPIRIN
Current Illness: Enlarged prostate; Factor V Leiden thrombophilia; Hypertension
Preexisting Conditions: Medical History/Concurrent Conditions: DVT (5 years ago); Pulmonary embolism (History of 4 PE''s five years ago)
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: Doppler exam; Result Unstructured Data: lower extremity blood clot, top of calf to mid thigh
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: DVT blood clot; A spontaneous report was received from a 60-year-old male consumer who received Moderna''s COVID-19 vaccine (mRNA-1273) and developed deep vein thrombosis (DVT) blood clot. The patient''s medical history, as provided by the reporter, included factor V Leiden, enlarged prostate, DVT, pulmonary embolism and hypertension. Concomitant medications reported included valsartan, alfuzosin, and acetylsalicylic acid. On 07 Jan 2021, approximately four days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 11 Jan 2021, the patient developed DVT blood clot and experienced leg pain so intense that he could not walk. A doppler exam showed the DVT was from the top of the calf to mid-thigh. Treatment for the event included a rivaroxaban starter pack with dose tapering. Action taken with mRNA-1273 in response to the event deep vein thrombosis (DVT) blood clot was not reported. The outcome of the event, DVT blood clot, was unknown.; Reporter''s Comments: This case concerns a 60-year-old male patient with a relevant medical history of factor V Leiden, DVT, pulmonary embolism and hypertension who received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. Patient experienced the medically significant unlisted event of Deep vein thrombosis approximately four days after administration of vaccine. Treatment for the event included rivaroxaban. Based on the temporal association between the use of the product and the event occurring after receiving the vaccine, a causal relationship cannot be excluded and the event of Deep vein thrombosis is possibly related to the product. Of note, the patient''s underlying Factor V Leiden which predispose to developing abnormal blood clots, and prior medical history of DVT with pulmonary embolism are considered risk factors to the occurrence of the event.


VAERS ID: 990361 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Indiana  
Vaccinated:2021-01-14
Onset:2021-01-14
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 013L20A / 1 LA / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Blindness unilateral, Retinal artery occlusion, Thrombosis
SMQs:, Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Glaucoma (broad), Optic nerve disorders (broad), Retinal disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Comerdol; LOSARTAN; HYDROCORTISONE; MELOXICAM; stomach pills
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No medical history reported)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: blindness in left eye; stroke in back of the eye; blood clot; A spontaneous report was received from a consumer concerning an 83-year-old, female patient who received Moderna''s COVID-19 Vaccine (mRNA-1273) and experienced blindness in left eye, blood clot, and stroke in back of the eye. The patient''s medical history was not provided. Concomitant medications reported included comerdol, losartan, hydrocortisone, meloxicam, and unspecified stomach pills. On 14 Jan 2021 at 10:15 am, approximately 3 hours and 45 minutes prior to the onset of the events, the patient received a dose of mRNA-1273 (Lot number: 013L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 14 Jan 2021 around 2:00 pm, the patient lost sight in her left eye as a result of a blood clot and stroke in the back of her eye. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, blindness in left eye, blood clot, and stroke in back of eye, was unknown.; Reporter''s Comments: This case concerns an 83-years-old female patient, who experienced a serious unexpected event of blindness unilateral, retinal artery occlusion, and thrombosis. The event of blindness unilateral and retinal artery occlusion occurred 3 hrs. after first dose of mRNA-1273, lot # 013L20A. The event of thrombosis occurred on an unspecified date after first dose of mRNA-1273, lot # 013L20A. Treatment included details were not provided. Concomitant medications included Comerdol, Losartan for blood pressure, Hydrocortisone, Meloxicam and stomach pills. Very limited information regarding this event has been provided at this time. Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded.


VAERS ID: 990713 (history)  
Form: Version 2.0  
Age: 76.0  
Sex: Male  
Location: Ohio  
Vaccinated:2021-01-06
Onset:2021-01-16
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Pain in extremity, Vasculitis
SMQs:, Vasculitis (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: metoprolol, lisinopril, colchicine , omeprazole ,
Current Illness: none
Preexisting Conditions: HTN , gout ,
Allergies: none
Diagnostic Lab Data: none so far
CDC Split Type:

Write-up: I am not sure if this is a reaction but 3 weeks after the first vaccination I developed painful spots in my fingers that now have continued for 10 days and some new have developed and the old ones have changed it seems to me as a vasculitis of some kind I will see my PCP on 2/19/21 but for now I am going to skip the second dosage


VAERS ID: 991693 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Male  
Location: Connecticut  
Vaccinated:2021-01-14
Onset:2021-01-26
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 013L20A / 1 RA / IM

Administered by: Public       Purchased by: ?
Symptoms: Deep vein thrombosis, Gait disturbance, Pain in extremity, Ultrasound Doppler
SMQs:, Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, venous (narrow), Parkinson-like events (broad), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: Intravascular Ultrasound 01/26/2021
CDC Split Type:

Write-up: I fell the pain in my leg immediatley the next day and was limping all day fromt hat point on. Deep Vein Rhrombosis (DVT) in right leg knee.


VAERS ID: 992280 (history)  
Form: Version 2.0  
Age: 41.0  
Sex: Female  
Location: New Mexico  
Vaccinated:2021-01-28
Onset:2021-01-29
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 029L20A / 2 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Erythema, Feeling hot, Petechiae, Rash
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Wellbutrin 150mg po 1x day
Current Illness: None
Preexisting Conditions: Depression
Allergies: pcn - UTI
Diagnostic Lab Data: none
CDC Split Type:

Write-up: Rash developed from Belly Button up to jaw line front and back sides of Torso and neck but no upper extremities , Red like a sunburn but with petechiae through out the full redness also and hot to touch. Stayed Friday PM through Sunday PM at bedtime. Woke up Monday AM without rash.


VAERS ID: 992338 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-01-26
Onset:2021-01-29
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / IM

Administered by: Other       Purchased by: ?
Symptoms: Computerised tomogram thorax, Pulmonary embolism, Pulmonary infarction
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: Covid-19
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: Chest CT scan
CDC Split Type:

Write-up: Pulmonary embolism, with pulmonary infarct


VAERS ID: 994588 (history)  
Form: Version 2.0  
Age: 51.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2021-01-14
Onset:2021-01-18
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Activated partial thromboplastin time normal, Alanine aminotransferase normal, Anion gap normal, Aspartate aminotransferase normal, Blood albumin normal, Blood bicarbonate normal, Blood calcium normal, Blood chloride normal, Blood creatine phosphokinase normal, Blood creatinine normal, Blood glucose normal, Blood iron normal, Blood magnesium normal, Blood phosphorus normal, Blood potassium normal, Blood sodium normal, Blood thyroid stimulating hormone, Blood thyroid stimulating hormone normal, Blood urea decreased, C-reactive protein normal, Eosinophil percentage decreased, Fatigue, Glomerular filtration rate, Glycosylated haemoglobin normal, Haematocrit normal, Haemoglobin normal, Immature granulocyte count, International normalised ratio normal, Lymphocyte count, Lymphocyte percentage, Mean cell haemoglobin concentration decreased, Mean cell haemoglobin normal, Mean cell volume normal, Monocyte count, Monocyte percentage, Muscle spasms, Neutrophil count, Neutrophil percentage, Paraesthesia oral, Petechiae, Platelet count normal, Prothrombin time normal, Pruritus, Red blood cell count normal, Red cell distribution width normal, SARS-CoV-2 test negative, Serum ferritin normal, Vitamin B12 normal, Vitamin D, White blood cell count normal
SMQs:, Anaphylactic reaction (broad), Haematopoietic leukopenia (broad), Haemorrhage terms (excl laboratory terms) (narrow), Dystonia (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Atorvastatin, Restasis, Estradiol, Linzess
Current Illness: N/A
Preexisting Conditions: htn, hyperlipidemia
Allergies: Macrodantin, Pravastatin
Diagnostic Lab Data: CBC, other labs (attached)
CDC Split Type:

Write-up: petechial rash, lips tingling, muscle cramps, pruritis, fatigue


Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=11&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19&VAXMAN=MODERNA

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166